论文部分内容阅读
观察依替米星治疗肺部感染的疗效。确诊肺部感染患者 11例 ,男 10例 ,女 1例 ,年龄 42～ 70岁 ,平均年龄 5 6岁。其中慢性阻塞性肺部疾病 (COPD)合并肺部感染 8例 ,肺癌合并肺部感染 2例 ,双下肺感染 1例。用硫酸依替米星 (ETM) 2 0 0 mg 5 %葡萄糖液 2 5 0 ml稀积后静脉滴注每日 1次 ,疗程 5～ 7d,总有效率90 .9%。 11例患者治疗前后均进行了细菌培养 ,共获致病菌株 2 0株 ,其中痰标本出现 2种以上菌株 7例 ,经用 ETM治疗一疗程后再行痰细菌培养 17株清除 ,细菌清除率 85 %。除 1例出现恶心而后自行消失外 ,未发现其他不良反应。认为硫酸依替米星使用方便有效 ,不良反应轻
To observe the efficacy of etimicin in the treatment of pulmonary infection. Eleven patients were diagnosed as pulmonary infection, including 10 males and 1 females, aged from 42 to 70 years with a mean age of 56 years. Among them, 8 cases of chronic obstructive pulmonary disease (COPD) complicated with pulmonary infection, 2 cases of lung cancer complicated with lung infection and 1 case of double lower lung infection. Intravenous drip infusion of ETM 200ml 5% dextrose 250ml once daily for 5-7 days, the total effective rate was 90.9%. Twenty-one cases of pathogenic bacteria were found in 11 patients before and after treatment. Among them, there were 7 cases of more than 2 strains in sputum specimens. After a course of treatment with ETM, 17 strains of bacteria were removed by sputum bacterial culture. The bacterial clearance rate 85%. In addition to one case of nausea and disappear on their own, no other adverse reactions were found. Etirotic sulfate that the use of convenient and effective, mild adverse reactions